Verona Pharma plc (VRNA)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch VRNA
See up to 3 months of VRNA. The 7-day demo opens the 1M and 3M ranges and puts VRNA on your watchlist.
Start 7-day demoLatest VRNA insider trades
- Kenneth Cunningham - DirectorOpen-market sale$142K
Lisa Deschamps - DirectorOpen-market sale$124K
About Verona Pharma plc (VRNA)
The SEC lists Verona Pharma plc under CIK 0001657312, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
VRNA Form 4 activity by transaction type, last 90 days
No Form 4 activity for VRNA in the last 90 days.
VRNA insider transactions (Form 4)
6960 Form 4 filings on record, the earliest from Oct 22, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| David R. Ebsworth - Director | Option exercise | Ordinary Shares | 24,000 | $0.00 | - | |
| David R. Ebsworth - Director | Open-market sale | Ordinary Shares | 1,904 | $13.14 | $25K | |
| David R. Ebsworth - Director | Option exercise | Restricted Stock Units | 24,000 | $0.00 | - | |
 Kathleen A. Rickard - Officer | Option exercise | Ordinary Shares | 86,064 | $0.00 | - | |
| Kathleen A. Rickard - Officer | Tax withholding / forfeiture | Ordinary Shares | 37,616 | $11.44 | $430K | |
| Kathleen A. Rickard - Officer | Grant or award | Restricted Share Units | 253,120 | $0.00 | - | |
| Kathleen A. Rickard - Officer | Option exercise | Restricted Share Units | 86,064 | $0.00 | - | |
 Andrew Fisher - Officer | Option exercise | Ordinary Shares | 86,064 | $0.00 | - | |
| Andrew Fisher - Officer | Tax withholding / forfeiture | Ordinary Shares | 39,464 | $11.44 | $452K | |
| Andrew Fisher - Officer | Grant or award | Restricted Share Units | 253,120 | $0.00 | - | |
| Andrew Fisher - Officer | Option exercise | Restricted Share Units | 86,064 | $0.00 | - | |
 David Zaccardelli - Officer | Option exercise | Ordinary Shares | 229,512 | $0.00 | - | |
| David Zaccardelli - Officer | Tax withholding / forfeiture | Ordinary Shares | 90,320 | $11.44 | $1.03M | |
| David Zaccardelli - Officer | Grant or award | Restricted Share Units | 675,048 | $0.00 | - | |
| David Zaccardelli - Officer | Option exercise | Restricted Share Units | 229,512 | $0.00 | - | |
| Mark W. Hahn - Officer | Option exercise | Ordinary Shares | 229,512 | $0.00 | - | |
| Mark W. Hahn - Officer | Tax withholding / forfeiture | Ordinary Shares | 90,320 | $11.44 | $1.03M | |
| Mark W. Hahn - Officer | Grant or award | Restricted Share Units | 675,048 | $0.00 | - | |
| Mark W. Hahn - Officer | Option exercise | Restricted Share Units | 229,512 | $0.00 | - | |
| David R. Ebsworth - Director | Option exercise | Ordinary Shares | 140,000 | $1.93 | $271K | |
| David R. Ebsworth - Director | Option exercise | Stock Option (Right to Exercise) | 140,000 | $0.00 | - | |
 Mahendra Shah - Director | Grant or award | Restricted Share Units | 96,000 | $0.00 | - | |
| David R. Ebsworth - Director | Grant or award | Restricted Share Units | 96,000 | $0.00 | - | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 67,608 | $5.00 | $338K | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 640,264 | $5.01 | $3.21M | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 162,800 | $5.01 | $815K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 58,184 | $5.00 | $291K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 640,048 | $5.01 | $3.20M | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 183,728 | $5.01 | $920K | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 23,240 | $5.00 | $116K | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 98,888 | $5.01 | $495K | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 3,200 | $5.00 | $16K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 12,936 | $5.00 | $65K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 98,704 | $5.01 | $494K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 1,600 | $5.00 | $8K | |
| Kathleen A. Rickard - Officer | Open-market sale | Ordinary Shares | 240,000 | $4.90 | $1.18M | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 1,600 | $5.00 | $8K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 1,600 | $5.00 | $8K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 800 | $5.00 | $4K | |
| David R. Ebsworth - Director | Open-market purchase | Ordinary Shares | 20,000 | $4.44 | $89K | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 2,400 | $5.00 | $12K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 2,400 | $5.00 | $12K | |
| David R. Ebsworth - Director | Open-market purchase | Ordinary Shares | 39,360 | $4.80 | $189K | |
| Christina Ackermann - Director | Open-market purchase | Ordinary Shares | 41,880 | $4.74 | $198K | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 46,888 | $4.38 | $205K | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 94,144 | $4.39 | $413K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 48,888 | $4.38 | $214K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 80,784 | $4.39 | $354K | |
| Kathleen A. Rickard - Officer | Grant or award | Ordinary Shares | 300,000 | $0.00 | - | |
| Kathleen A. Rickard - Officer | Grant or award | Ordinary Shares | 50,000 | $0.00 | - | |
| Kathleen A. Rickard - Officer | Tax withholding / forfeiture | Ordinary Shares | 65,936 | $4.24 | $280K | |
| Andrew Fisher - Officer | Grant or award | Ordinary Shares | 300,000 | $0.00 | - | |
| David Zaccardelli - Officer | Grant or award | Ordinary Shares | 800,000 | $0.00 | - | |
| David Zaccardelli - Officer | Grant or award | Ordinary Shares | 200,000 | $0.00 | - | |
| David Zaccardelli - Officer | Tax withholding / forfeiture | Ordinary Shares | 245,952 | $4.24 | $1.04M | |
| Mark W. Hahn - Officer | Grant or award | Ordinary Shares | 800,000 | $0.00 | - | |
| Mark W. Hahn - Officer | Grant or award | Ordinary Shares | 200,000 | $0.00 | - | |
| Mark W. Hahn - Officer | Tax withholding / forfeiture | Ordinary Shares | 245,952 | $4.24 | $1.04M | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 16 | $4.38 | $70 | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 140,000 | $4.38 | $613K | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 4,800 | $4.38 | $21K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 141,360 | $4.38 | $619K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 3,200 | $4.38 | $14K | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 245,784 | $4.38 | $1.08M | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 110,456 | $4.38 | $484K | |
| David Zaccardelli - Officer | Open-market sale | Ordinary Shares | 157,912 | $4.39 | $693K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 249,728 | $4.38 | $1.09M | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 116,696 | $4.38 | $511K | |
| Mark W. Hahn - Officer | Open-market sale | Ordinary Shares | 159,344 | $4.38 | $699K |
VRNA insider trading FAQ
What is the latest insider trade for VRNA?
Verona Pharma plc (VRNA) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-10-07. The full record for VRNA runs to 60 Form 4 filings, the earliest from 2024-10-22. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VRNA stock?
No insider purchases of VRNA were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling VRNA stock?
No insider sales of VRNA were filed in the last 90 days. 46 sales are on record for this company.
Where can I see VRNA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VRNA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Andrew Fisher view on EDGAR
- - Kathleen A. Rickard view on EDGAR
- - Michael Austwick view on EDGAR
- - Anders Ullman view on EDGAR
- - Lisa Deschamps view on EDGAR
- - James Aloysius Brady view on EDGAR
- - Kenneth Cunningham view on EDGAR
- - Christina Ackermann view on EDGAR
- - Martin Edwards view on EDGAR
- - David Zaccardelli view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where VRNA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VRNA with a 7-day demo
- VRNA on your watchlist
- Every VRNA Form 4 filing on record
- Up to 3 months of VRNA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
